Source comparison
BPC-157 for MMA Recovery Research: Comparison of Administration Models
Local Subcutaneous (peri-injury) 250–500 mcg once daily, 14–28 days 5–7 days (ultrasound-visible collagen reorganization) Acute tendon/ligament tears, localized muscle strains Fastest observed healing in published models; requires precise injection technique w
This comparison does not assign a generated winner or score.
- Local Subcutaneous (peri-injury)
- 250–500 mcg once daily, 14–28 days
- 5–7 days (ultrasound-visible collagen reorganization)
- Acute tendon/ligament tears, localized muscle strains
- Fastest observed healing in published models; requires precise injection technique within 2 cm of injury site
- Systemic Subcutaneous (abdominal)
- 200–400 mcg once or twice daily, 21–42 days
- 10–14 days (functional improvement in range of motion testing)
- Chronic tendinopathy, diffuse soft tissue damage, multiple injury sites
- Broader systemic effect; useful when injury location makes local injection impractical (e.g., deep rotator cuff)
- Intramuscular (rare in current research)
- 300–500 mcg twice daily, 14 days
- 7–10 days (reduced inflammatory markers on bloodwork)
- Muscle belly tears, compartment syndrome research
- Limited published data; theoretically higher local concentration but increased injection site soreness reported in pilot studies
- Oral Administration (experimental)
- 500–1000 mcg once daily, 28+ days
- 21+ days (inconsistent results across studies)
- Gastric ulcer healing models; not validated for musculoskeletal repair
- Bioavailability concerns due to gastric acid degradation; not recommended for sports medicine research at this time